Antenatal Care And Pre-eclampsia

Most pregnancies progress normally and without the need to be accompanied by medical intervention. One purpose of antenatal care is to allow the surveillance of all pregnancy complications so that it can perform detection as early as possible. In developing countries, many pregnant women who did not receive adequate antenatal care and this can lead to consequences serius.1 Antenatal care is important to ensure that the natural process of pregnancy was normal and remained so on. Pregnancy can develop into any problems or complications at any time. 

Now it is generally accepted that every pregnancy carries risks for the mother. WHO estimates that about 15% of all pregnant women will develop complications associated with pregnancy and can be life-threatening. Of the 5.6 million pregnant women in Indonesia, a large number will experience a complication or problem that could rise to fatal. Demographic and health surveys conducted in 1997 states that from 1992 to 1997, there were 26% of women with live births had complications. New in half a century held monitoring pregnant women regularly and given. With the venture turned out to mortality and maternal and neonatal morbidity decreases. 

Obstetric care consists of monitoring and treatment of women during pregnancy and at delivery, maintenance and inspection of women after childbirth, infant care, and maintenance of lactation. In a broader sense the efforts started earlier with improved health and well-being of adolescents as a potential father and mother, and to assist them in mengembanghkan a reasonable attitude towards family life and the family in society. It also includes guidance for the future they become good fathers and mothers as well as an understanding of the issues concerned with reproductive health.

This article can be download

Download Please

VALPROATE ACID

INDICATIONS

All forms of epilepsy

CONS INDICATION

Active liver disease, history of severe liver disease in the family, pancreatitis, porphyria.

Attention: liver disorders (monitor liver function before and during the first 6 months of therapy), particularly in patients who at high risk: children <3 years, patients with metabolic disorders, degenerative disorders, brain disorders or severe seizures associated with mental retardation or multiple antiepileptic therapy . Also in patients with renal impairment, pregnancy, lactation, and SLE. Avoid breaking abruptly drug.

DOSE

Adults and children> 12 years of the initial dose of 600 mg daily in 2 divided doses, preferably after meals. Raise the dose of 200 mg a day after an interval of 3 days, maximum 2.5 g daily in divided doses. Maintenance dose 1-2 g daily (20-30 mg / kg daily).

Children> 20 kg initial dose of 20 mg / kg daily in divided doses.

Children <12 years, weight> 20 kg initial dose of 400 mg daily in divided doses, up to a range of 20-30 mg / kg per day, maximum 35 mg / kg daily.

SIDE EFFECTS

Gastrointestinal irritation, nausea, appetite and weight increased, tremor, hair loss, swelling, thrombocytopenia, platelet clumping resistance, impaired liver function and (rarely) fatal liver failure.

Immediately discontinue treatment if symptoms encountered limp, swelling, abdominal pain, vomiting, anorexia, jaundice, severe drowsiness, and lost control of seizures.

SPECIMENS:

Oral Liquid 200 mg / 5 ml, 100 mg tablets, enteric-coated tablet 200 mg and 500 mg.

INTERACTION

Name of Drug Interactions with Valproate Acid

1. Effect of aspirin rose valproic
2. Antibiotic levels in plasma valproate may be reduced by doripenem and ertapenem, were reduced by meropenem, and metabolism is inhibited by erythromycin
3. Another anticonvulsant valproate in plasma levels reduced by carbamazepin, and the active metabolite carbamazepin increased.
4. Gastrointestinal drug metabolism is inhibited by valproic simetidine

Pouchers Perfumes Cosmetics And Soaps 10th Edition

Table of sContributors. Preface. Foreword. Part 1: Historical Background. 1. W.A. Poucher's Influence on the Early 20th Century Cosmetic Industry; H. Butler. 2. Cosmetics through the Ages; H. Butler. Part 2: Cosmetics For Everyday Use. 3. Antiperspirants and Deodorants; P. Klepak, J. Walkey. 4. Bath and Shower Products; A.L.L. Hunting. 5. Colouring Materials Used in Decorative Cosmetics and Colour Matching; P. Riley. 6. Decorative Cosmetics; P. Riley. 7. Dental Hygiene; S. Mason, S. Hodgetts. 8. Hair Treatments; F.J. Mottram, C.E. Lees. 9. Hair Shampoos; F.J. Mottram, C.E. Lees. 10. Haircolourants; B.P. Murphy. 11. Manicure Preparations; M.L. Schlossman. 12. Men's Toiletries; P. Paniccia. 13. Pressurized Dispensers; J. McAllister. 14. Skin Preparations; G. Abamba. 15. Soap; M.J. Willcox. 16. Sun Damage and Sunscreen Preparations; M. Brown, N. Fardell. Part 3: Stability and Safety. 17. Analytical Methods; K. Spears. 18. Efficacy Testing of Cosmetics and Toiletries; M. Roberts. 19. Emulsion Theory; J.L. Knowlton. 20. Legislation and Safety Regulations for Cosmetics in the United States, the European Union and Japan; P.D. Wilkes. 21. Microbiological Control of Cosmetics; H. Butler. 22. Safety; J.D. Middleton. 23. Stability; J.S. Cannell. Part 4: Perfumes: Their Manufacture in Products and Psychology in Use. 24. Perfume and the Manufacture of Consumer Products; N.J. Van Abbé. 25. The Psychology of Fragrance and

This Ebook Can be Download:

Download Please

Mirror

http://mihd.net/sv1fuq

Pharmaceutical Compounding and dispensing

This book has been written as a student guide to extemporaneous pharmaceutical compounding and dispensing. It has been designed to assist the student compounder in understanding the key dosage forms encountered within extemporaneous dispensing. Included is a summary of the key principles relating to labelling and packaging, along with a summary of the formulation of each dosage type. In addition, worked examples and questions have been included to allow the compounder to practise extemporaneous formulation exercises.

This ebook can be download at:

Download In Here